MY163067A - Peg or peg block copolymers for treating colorectal cancer - Google Patents
Peg or peg block copolymers for treating colorectal cancerInfo
- Publication number
- MY163067A MY163067A MYPI2013001602A MYPI2013001602A MY163067A MY 163067 A MY163067 A MY 163067A MY PI2013001602 A MYPI2013001602 A MY PI2013001602A MY PI2013001602 A MYPI2013001602 A MY PI2013001602A MY 163067 A MY163067 A MY 163067A
- Authority
- MY
- Malaysia
- Prior art keywords
- peg
- colorectal cancer
- block copolymers
- treating colorectal
- treating
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title abstract 4
- 208000001333 Colorectal Neoplasms Diseases 0.000 title abstract 4
- 229920001400 block copolymer Polymers 0.000 title abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- 229920001993 poloxamer 188 Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1018650.0A GB201018650D0 (en) | 2010-11-04 | 2010-11-04 | Methods and compositions |
| US41212810P | 2010-11-10 | 2010-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY163067A true MY163067A (en) | 2017-08-15 |
Family
ID=43414365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2013001602A MY163067A (en) | 2010-11-04 | 2011-11-04 | Peg or peg block copolymers for treating colorectal cancer |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20130216493A1 (enExample) |
| EP (1) | EP2635289B1 (enExample) |
| JP (1) | JP5917537B2 (enExample) |
| KR (1) | KR20130109171A (enExample) |
| CN (1) | CN103313719A (enExample) |
| AR (1) | AR083770A1 (enExample) |
| AU (1) | AU2011324996B2 (enExample) |
| BE (1) | BE1019494A3 (enExample) |
| BR (1) | BR112013011012A2 (enExample) |
| CA (1) | CA2816839A1 (enExample) |
| EA (1) | EA201300540A1 (enExample) |
| ES (1) | ES2401269B1 (enExample) |
| GB (1) | GB201018650D0 (enExample) |
| MX (1) | MX349690B (enExample) |
| MY (1) | MY163067A (enExample) |
| NL (1) | NL2007715C2 (enExample) |
| NZ (1) | NZ611145A (enExample) |
| SG (1) | SG189533A1 (enExample) |
| TW (1) | TWI606832B (enExample) |
| UA (1) | UA107998C2 (enExample) |
| WO (1) | WO2012059725A1 (enExample) |
| ZA (1) | ZA201304052B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
| KR20170098980A (ko) | 2012-09-11 | 2017-08-30 | 노어긴 비.브이. | Peg 및 아스코르베이트를 포함하는 조성물 |
| AR093153A1 (es) * | 2012-10-26 | 2015-05-20 | Northshore Univ Healthsystem | Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello |
| CN103083733A (zh) * | 2013-02-19 | 2013-05-08 | 华熙福瑞达生物医药有限公司 | 一种医用体腔器械导入水性润滑剂 |
| WO2020180549A1 (en) * | 2019-03-05 | 2020-09-10 | Dow Global Technologies Llc | Inducing caspase activity |
| US12251399B2 (en) | 2019-03-05 | 2025-03-18 | Dow Global Technologies Llc | Inducing caspase activity |
| CN113490501B (zh) * | 2019-03-05 | 2024-05-24 | 陶氏环球技术有限责任公司 | 用于诱导胱天蛋白酶活性的聚乙二醇衍生物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2784897B1 (fr) | 1998-10-27 | 2002-11-29 | Agronomique Inst Nat Rech | Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux |
| JP5276435B2 (ja) * | 2005-05-06 | 2013-08-28 | セイリックス ファーマシューティカルズ， インコーポレイティッド | ポリエチレングリコールの結腸の下剤組成物 |
| US8457025B2 (en) * | 2009-08-28 | 2013-06-04 | Telefonaktiebolaget L M Ericsson (Publ) | Method and network node for selecting a network prefix to be advertised in a communication network |
-
2010
- 2010-11-04 GB GBGB1018650.0A patent/GB201018650D0/en not_active Ceased
-
2011
- 2011-04-11 UA UAA201307040A patent/UA107998C2/uk unknown
- 2011-11-04 AR ARP110104129A patent/AR083770A1/es unknown
- 2011-11-04 BR BR112013011012A patent/BR112013011012A2/pt not_active IP Right Cessation
- 2011-11-04 WO PCT/GB2011/001561 patent/WO2012059725A1/en not_active Ceased
- 2011-11-04 CN CN201180064013XA patent/CN103313719A/zh active Pending
- 2011-11-04 CA CA2816839A patent/CA2816839A1/en not_active Abandoned
- 2011-11-04 EP EP11785050.3A patent/EP2635289B1/en active Active
- 2011-11-04 BE BE2011/0645A patent/BE1019494A3/fr not_active IP Right Cessation
- 2011-11-04 AU AU2011324996A patent/AU2011324996B2/en not_active Ceased
- 2011-11-04 NL NL2007715A patent/NL2007715C2/en not_active IP Right Cessation
- 2011-11-04 EA EA201300540A patent/EA201300540A1/ru unknown
- 2011-11-04 NZ NZ611145A patent/NZ611145A/en not_active IP Right Cessation
- 2011-11-04 KR KR1020137013977A patent/KR20130109171A/ko not_active Ceased
- 2011-11-04 TW TW100140231A patent/TWI606832B/zh not_active IP Right Cessation
- 2011-11-04 MX MX2013004963A patent/MX349690B/es active IP Right Grant
- 2011-11-04 SG SG2013032008A patent/SG189533A1/en unknown
- 2011-11-04 MY MYPI2013001602A patent/MY163067A/en unknown
- 2011-11-04 ES ES201131772A patent/ES2401269B1/es not_active Expired - Fee Related
- 2011-11-04 JP JP2013537197A patent/JP5917537B2/ja not_active Expired - Fee Related
- 2011-11-04 US US13/883,262 patent/US20130216493A1/en not_active Abandoned
-
2013
- 2013-06-03 ZA ZA2013/04052A patent/ZA201304052B/en unknown
-
2016
- 2016-04-21 US US15/134,410 patent/US20160228467A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SG189533A1 (en) | 2013-05-31 |
| WO2012059725A8 (en) | 2013-05-30 |
| AU2011324996A1 (en) | 2013-05-02 |
| TW201304785A (zh) | 2013-02-01 |
| KR20130109171A (ko) | 2013-10-07 |
| TWI606832B (zh) | 2017-12-01 |
| UA107998C2 (uk) | 2015-03-10 |
| AR083770A1 (es) | 2013-03-20 |
| JP2013544809A (ja) | 2013-12-19 |
| US20130216493A1 (en) | 2013-08-22 |
| EA201300540A1 (ru) | 2013-09-30 |
| ES2401269B1 (es) | 2014-02-19 |
| NL2007715A (en) | 2012-05-07 |
| AU2011324996B2 (en) | 2015-10-08 |
| CA2816839A1 (en) | 2012-05-10 |
| MX349690B (es) | 2017-08-09 |
| ZA201304052B (en) | 2014-02-26 |
| BE1019494A3 (fr) | 2012-07-03 |
| MX2013004963A (es) | 2013-08-27 |
| NZ611145A (en) | 2015-07-31 |
| US20160228467A1 (en) | 2016-08-11 |
| JP5917537B2 (ja) | 2016-05-18 |
| ES2401269A1 (es) | 2013-04-18 |
| EP2635289A1 (en) | 2013-09-11 |
| GB201018650D0 (en) | 2010-12-22 |
| WO2012059725A1 (en) | 2012-05-10 |
| BR112013011012A2 (pt) | 2016-08-23 |
| NL2007715C2 (en) | 2012-10-16 |
| CN103313719A (zh) | 2013-09-18 |
| EP2635289B1 (en) | 2020-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY163067A (en) | Peg or peg block copolymers for treating colorectal cancer | |
| MX2013012387A (es) | Composicion que comprende aflibercept, acido folinico, 5-fluorouracilo (5-fu) e irinocetan (folfiri). | |
| EP4406557A3 (en) | Materials and methods for improving gastrointestinal function | |
| WO2012048099A3 (en) | Nanoparticle-loaded cells | |
| IL225597A0 (en) | Pharmaceutical preparation, methods of treatment and its uses | |
| MX2015007053A (es) | Compuestos dimericos. | |
| SG10201903119QA (en) | Polypeptide vaccine | |
| BR112012011485A2 (pt) | "composições e métodos para tratar náusea e vômito centralmente mediados". | |
| PH12012501365A1 (en) | Stabilization of zinc oxide film in oral compositions | |
| WO2010083385A3 (en) | Compounds for reducing drug resistance and uses thereof | |
| HK1210953A1 (en) | Methods for treatment of atherosclerosis | |
| WO2009095261A3 (en) | Vaccine compositions | |
| WO2011113060A3 (en) | Antiviral compounds and methods of use thereof | |
| PH12017502216A1 (en) | Nucleic acid-cationic polymer compositions and methods of making and using the same | |
| GB2496342B (en) | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia | |
| WO2011121576A3 (en) | Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae | |
| WO2012073047A3 (en) | Compositions and methods | |
| MY161601A (en) | Films and compositions comprising the same | |
| MX2013007230A (es) | Sistemas de polimero. | |
| WO2009114461A3 (en) | Angiotensin (1-7) dosage forms and uses thereof | |
| IN2014DN08385A (enExample) | ||
| WO2012170742A3 (en) | Treatment and prevention of cancer with hmgb1 antagonists | |
| WO2012074725A3 (en) | Immunomodulatory methods and systems for treatment and/or prevention of hypertension | |
| EA201301205A1 (ru) | Способ предупреждения и/или лечения плоскоклеточного рака головы и шеи и композиция в нем используемая | |
| MX344189B (es) | Formulaciones de mazindol. |